AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Almitas Capital LLC's Holding History (CIK: 0001596468)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 2,122,597 Value ($000) $25,641 Avg Close $13.58 Range $11.69 - $16.96

Q3 2025

Shares 2,122,597 Value ($000) $28,846 Avg Close $9.41 Range $5.97 - $15.14

Q2 2025

Shares 2,122,597 Value ($000) $13,606 Avg Close $4.86 Range $3.11 - $6.70

Q1 2025

Shares 2,122,597 Value ($000) $7,514 Avg Close $3.56 Range $2.60 - $4.18

Q4 2024

Shares 2,032,370 Value ($000) $7,682 Avg Close $4.71 Range $2.91 - $7.27

Q3 2024

Shares 1,988,563 Value ($000) $6,443 Avg Close $2.25 Range $1.62 - $3.33

Q2 2024

Shares 1,903,851 Value ($000) $3,617 Avg Close $1.94 Range $1.57 - $2.89

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	2,122,597	$25,641	$13.58	$11.69 - $16.96
Q3 2025	2,122,597	$28,846	$9.41	$5.97 - $15.14
Q2 2025	2,122,597	$13,606	$4.86	$3.11 - $6.70
Q1 2025	2,122,597	$7,514	$3.56	$2.60 - $4.18
Q4 2024	2,032,370	$7,682	$4.71	$2.91 - $7.27
Q3 2024	1,988,563	$6,443	$2.25	$1.62 - $3.33
Q2 2024	1,903,851	$3,617	$1.94	$1.57 - $2.89